Alignment Healthcare (NASDAQ:ALHC) Stock Rating Upgraded by Wall Street Zen

Alignment Healthcare (NASDAQ:ALHC) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday.

A number of other research firms have also recently issued reports on ALHC. The Goldman Sachs Group reiterated a “buy” rating and set a $22.00 target price on shares of Alignment Healthcare in a report on Monday, November 3rd. Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 28th. UBS Group lifted their target price on Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, January 14th. Robert W. Baird set a $28.00 target price on Alignment Healthcare in a research note on Friday, January 30th. Finally, TD Cowen upped their price target on Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a research report on Friday, January 16th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Alignment Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $23.32.

Alignment Healthcare Stock Up 2.8%

Alignment Healthcare stock opened at $21.75 on Friday. The company has a 50 day moving average of $20.79 and a 200-day moving average of $17.84. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. Alignment Healthcare has a twelve month low of $11.63 and a twelve month high of $23.87. The stock has a market capitalization of $4.35 billion, a PE ratio of -181.25, a price-to-earnings-growth ratio of 5.73 and a beta of 1.16.

Insider Buying and Selling

In other Alignment Healthcare news, President Dawn Christine Maroney sold 282,070 shares of the business’s stock in a transaction that occurred on Monday, December 29th. The stock was sold at an average price of $18.74, for a total transaction of $5,285,991.80. Following the transaction, the president owned 1,385,167 shares of the company’s stock, valued at $25,958,029.58. The trade was a 16.92% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Robert L. Scavo sold 69,541 shares of the company’s stock in a transaction that occurred on Monday, December 29th. The stock was sold at an average price of $18.74, for a total value of $1,303,198.34. Following the sale, the insider owned 503,014 shares in the company, valued at approximately $9,426,482.36. This represents a 12.15% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,923,532 shares of company stock valued at $37,591,938 in the last ninety days. 6.60% of the stock is owned by company insiders.

Institutional Trading of Alignment Healthcare

Large investors have recently added to or reduced their stakes in the company. Teacher Retirement System of Texas boosted its stake in shares of Alignment Healthcare by 85.8% during the 3rd quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company’s stock worth $1,794,000 after acquiring an additional 47,472 shares during the period. Y Intercept Hong Kong Ltd bought a new position in Alignment Healthcare during the third quarter worth $3,499,000. Inspire Investing LLC acquired a new position in shares of Alignment Healthcare in the third quarter valued at $1,129,000. Ameritas Investment Partners Inc. raised its position in shares of Alignment Healthcare by 32.9% in the second quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock valued at $182,000 after purchasing an additional 3,225 shares during the period. Finally, Schroder Investment Management Group raised its position in shares of Alignment Healthcare by 28.7% in the second quarter. Schroder Investment Management Group now owns 248,163 shares of the company’s stock valued at $3,437,000 after purchasing an additional 55,314 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.